Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Last revisionBoth sides next revision
home:starting:safety_warnings [10.19.2018] – [Patients' physicians must understand the Marshall Protocol] sallieqhome:starting:safety_warnings [10.19.2018] – [Notes and comments] sallieq
Line 66: Line 66:
  
  
-===== Immunopathology is dangerous and may be difficult to control =====+===== Immunopathology could become dangerous and may be difficult to control =====
  
 <mainarticle> [[home:mp:immunopathology|Immunopathology]] </article> <mainarticle> [[home:mp:immunopathology|Immunopathology]] </article>
Line 87: Line 87:
  
   * Updated wording, but still think it could be made even better with more work. --Joyful May'13   * Updated wording, but still think it could be made even better with more work. --Joyful May'13
-  * added "Xarelto increases the risk of bleeding and can cause serious or fatal bleeding. A specific antidote for rivaroxaban is not available. Because of high plasma protein binding, rivaroxaban is not expected to be dialyzable." --Sallie Q May15  
-  * altered 3rd line to 'sufficient olmesartan medoxomil (Benicar) to ensure that patient does not run out if there is a delay in delivery or in renewing prescription' --- //Sallie Q 11.02.2016// 
  
-alteration ( @ Patients must understand..) why the use of  telmisartan or azithromycin is considered particularly dangerous  --- //Sallie Q 09.15.2017//+ 
home/starting/safety_warnings.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.